Select Medical stock ends public trading after a USD 3.9 billion buyout

Published on 09/30/2026 at 17:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Select Medical stock reported Q1 2026 revenue of USD 1,421.5 million, up 5.00 percent year over year. The buyout paid USD 16.50 per share in cash.

SEM, US81642T1007, Illustration mit AI erstellt.

Select Medical stock (ISIN US81642T1007) ended its public-market run after a USD 3.9 billion buyout was completed on June 30, 2026. Becker's Hospital Review reported on September 8, 2026, that the transaction made Select Medical a privately held company.

Buyout closes at USD 16.50

The consortium led by co-founder Robert Ortenzio acquired Select Medical for USD 3.9 billion, with USD 16.50 in cash paid for each outstanding share. StockTitan reports that the deal also included a USD 1.0 billion incremental term loan and ended the company's NYSE trading and SEC reporting.

The transaction followed a March 2026 agreement involving Welsh, Carson, Anderson and Stowe and Select Medical executives. The USD 16.50 consideration gives investors a concrete reference point for the final public-market valuation, while the change in ownership shifts the company from a listed healthcare operator to a private platform.

Revenue rises as profit falls

For the first quarter of 2026, revenue reached USD 1,421.5 million, up 5.00 percent from USD 1,353.2 million in the year-earlier quarter. Net income moved in the opposite direction, falling from USD 74.7 million to USD 63.8 million, while earnings per share declined from USD 0.44 to USD 0.35, according to StockTitan in its April 30, 2026 filing summary.

The rehabilitation hospital segment supplied the clearest operating growth, with revenue increasing 14.50 percent to USD 351.9 million in the quarter. That performance contrasts with the decline in group net income and shows why segment execution mattered alongside the completed ownership change.

Select Medical's operating footprint

As of March 31, 2026, Select Medical operated 103 critical illness recovery hospitals in 28 states, 41 rehabilitation hospitals in 15 states and 1,912 outpatient rehabilitation clinics in 37 states and Washington, D.C. Becker's Hospital Review published those figures on September 8, 2026.

Public trading ends after the deal

Select Medical's NYSE listing concluded with the June 30, 2026 transaction, and the USD 16.50 cash consideration now defines the last publicly quoted equity value discussed in the buyout record. The company continues as a private healthcare operator with hospitals, rehabilitation facilities and outpatient clinics across the United States.